Pancreatic Cancer Research

ResearcherFred and Pamela Buffett Cancer CenterActive in the last 2 years

Clara S. Mundry

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8272-5360; OpenAlex author ID A5044695745. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 4

  1. A MUC1-ALIX complex regulates extracellular vesicle cargo loading with activated SRC to enhance pancreatic cancer progression. Co-author DOI 10.1016/j.canlet.2026.218411↗
  2. MUC16 drives macrophage-mediated immunosuppression in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2026.218927↗
  3. Single-cell RNA-sequencing of human spleens reveals an IDO-1+ tolerogenic dendritic cell subset in pancreatic cancer patients that is absent in normal individu… Co-author DOI 10.1016/j.canlet.2024.217321↗
  4. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal. Co-author DOI 10.1016/j.bbcan.2020.188387↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Anthony Hollingsworth · 4 shared papers, 2020–2026 · strength 0.83
  2. Ying Huang · 2 shared papers, 2026 · strength 0.50
  3. Kyle L. McAndrews · 2 shared papers, 2024–2026 · strength 0.43
  4. Paul M. Grandgenett · 2 shared papers, 2024–2026 · strength 0.43
  5. Pankaj Kumar Singh · 2 shared papers, 2020–2026 · strength 0.40
  6. Kamiya Mehla · 2 shared papers, 2020–2024 · strength 0.33
  7. Christabelle Rajesh · 1 shared paper, 2026 · strength 0.25
  8. Thomas C. Caffrey · 1 shared paper, 2026 · strength 0.25
  9. Satish Sagar · 1 shared paper, 2026 · strength 0.25
  10. Prakash Radhakrishnan · 1 shared paper, 2026 · strength 0.25
  11. Jesse L. Cox · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.